Latest news
Loading news…
HalioDx
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Marseille, Provence-Alpes-Cote d'Azur, France Founded 2014 51-100 employees For Profit
HalioDx designs and develops diagnostic tests in oncology utilizing the immune contexture of cancers.
HalioDx was acquired by Veracyte in 2021 for $318M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
11
Patents
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 22
- Patents granted
- 1
- Trademarks
- 0
- Top patent class
- Testing
- IT spend
- $9M
Company Info
- Founded
- 2014
- Employees
- 51-100
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 5
- Events
- 1
- HQ
- Marseille, Provence-Alpes-Cote d'Azur, France
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Jun 1, 2021
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 1.7
- Trend (30d)
- 3.7
- Trend (90d)
- 4.1
Key People at HalioDx
Chief Scientific Officer
CEO
EVP, Partnerships BU
11
professional contacts at HalioDx
Contact execs at HalioDx →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to HalioDx
Loading news…
FAQs about HalioDx
People who checked this page also checked these
Browse the full Acquirezy directory.